The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

ConditionsCardiogenic Shock Malignant Arrhythmias Ischemic or Valvular Heart Failure Drepanocytosis and Thoracic Syndrome Pulmonary Thromboembolisms Sepsis ARDS (Acute Respiratory Distress Syndrome)Intoxication Cardiac Arrest (CA)Postcardiotomy Heart Failure Acute Respiratory Failure

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeUp to 90

SponsorUniversity of Genova

About this trial

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010

Disqualifiers

Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)

Trial population

All consecutive patients implanted with a VV-ECMO, VA-ECMO or VAV-ECMO device by the UHM HeartTeam

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

1,200 Participants

are grouped into 3 trial groups

Group A: VV-ECMO

Group B: VA-ECMO

Group C: VAV-ECMO

Trial outcomes

Primary outcomes

Mortality at 30 days

Number of deceased participants as assessed at 30 days after ECMO implantation

Time frame

from canula implantation to 30 days afterwards

Secondary outcomes

Number of participants with major adverse events

Major Adverse events (AE; numbers and rates) as assessed by the consensus statement of the mechanical circulatory support academic research consortium

Time frame

From canula implantation to up to 6 months after ECMO implantation

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Genova

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: